Authors: I. Míčková 1; R. Pilka 2; M. Lubušký 2; Milan Kudela 2 Authors‘ workplace: Ústav lékařské genetiky a fetální medicíny, LF UP a FN, Olomouc, přednosta prof. MUDr. J. Šantavý, CSc. 1; Gynekologicko-porodnická klinika, LF UP a FN, Olomouc, přednosta prof. MUDr. M. Kudela, CSc. 2 Published in: Ceska Gynekol 2006; 71(4): 355-360 Category: Original Article
Objective: To evaluate the importance of molecular markers for prognosis and pathogenesis of endometrial carcinoma.
Design: A review article.
Setting: Department of Medical Genetics and Fetal Medicine, University Hospital, Olomouc, Department of Obstetrics and Gynecology, University Hospital, Olomouc.
Methods: This article reviews the current knowledge of the molecular changes in the development of endometrial cancer, and their possible importance for the patient’s prognosis.
Conclusion: The new molecular biomarkers are apparently going to play a significant role in the management of endometrial carcinoma treatment in the near future.
Key words: carcinoma, endometrium, marker, prognosis
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
